【中文名称】:金黄色葡萄球菌 (MRSA) ATCC 33591 【英文名称】:无 【CAS.编号】:无 【详细描述】: Culti-Loops 质控菌株接种环为5支/包装,除弯曲菌属需冷冻保存(-18℃)外,其它都应在2-8℃保存。Culti-loops产品说明书下载 << 上一篇:金黄色葡萄球菌 ATCC 33862 ...
elegans, and the most virulent strain (ATCC 33591) was selected for further analyses. In a final experiment, full-grown C. elegans were exposed to the test strain for 3 days and subsequently treated with 8 mg DCX l(-1) and 8 mg TZ l(-1) for 2 days. This resulted in a 14-fold ...
本发明提供了前述的药物在制备治疗耐药葡萄球菌感染性疾病的药物中的用途;优选地,所述耐药葡萄球菌感染性疾病为耐甲氧西林金黄色葡萄球菌感染性疾病;更优选地,所述的耐甲氧西林金黄色葡萄球菌感染性疾病为耐甲氧西林金黄色葡萄球菌ATCC43300或耐甲氧西林金黄色葡萄球菌ATCC33591感染性疾病。 本发明最后提供了前述的联合...
aureus ATCC 33591 was included as a reference strain for quality control. Isolates were identified as S. aureus by the standard microbiological procedures[24]. Then the following tests were carried out: I- Detection of methicillin resistance This was carried out according to NCCLS guidelines using ...
A series of alkyl gallates was found to show antibacterial activity against Gram-positive bacteria including methicillin resistant Staphylococcus aureus (MRSA) strains. For example, dodecyl gallate exhibited bactericidal activity against MRSA ATCC 33591 strain with an MBC of 74 μM. The time–kill cur...
[118] also determined the in vitro antibacterial activity of Radachlorin® against 2 MRSA strains (MRSA ATCC 33591 and MRSA PTCC 1764) and reported a 6.28 log10 CFU reduction (Table 3). The major component of Radachlorin® was SnCe6. Table 3. Summary of included studies under chlorin ...
aureus ATCC 33591 was included as a reference strain for quality control. Isolates were identified as S. aureus by the standard microbiological procedures[24]. Then the following tests were carried out: I- Detection of methicillin resistance This was carried out according to NCCLS guidelines using ...
1.3.3 单一基因 PCR 扩增 根据所设计的引物,在相同条件下以标准菌 EC ATCC 25922、KP ATCC 700603、SA ATCC 29213 和 MRSA ATCC 33591 的 DNA 为模板,分别对其进行 16S rDNA、EC phoA、KP mdh、SA femA 和 MRSA mecA 单一基因 PCR 扩增。PCR 反应体系(25 μL):2×QIAGEN Multiplex PCR Master Mix 1 ...
摘要: 本发明涉及原花青素协同增效头孢噻呋钠抗MRSA耐药菌作用中.为此,本发明提供一种抗MRSA耐药菌的药物组合,所述组合为原花青素和头孢噻呋钠的组合,本发明通过体外试验验证,原花青素和头孢噻呋钠两者合用具有良好的协同增效作用,对MRSA耐药菌株ATCC33591和其他临床菌株均有效....